Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer.


BACKGROUND Agents such as aflibercept, which target the angiogenic pathway, are of great interest as candidates for the management of metastatic differentiated thyroid cancer. Here, we report a patient who developed a hemorrhagic abdominal pseudoaneurysm shortly after being started on this drug. PATIENT FINDINGS The patient was a 67-year-old woman being… (More)
DOI: 10.1089/thy.2011.0413


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics